Study guide

IC3D and epithelial or Bowman-layer dystrophies

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

IC3D and epithelial or Bowman-layer dystrophies

Key Takeaways Explain This Topic AI

IC3D categories describe the strength of diagnostic evidence rather than the severity of an individual patient’s disease.

Epithelial and Bowman-layer dystrophies differ in deposits, recurrence and genetic basis.

Use genotype, clinical appearance and histology together; not every corneal dystrophy is a TGFBI disorder.

Last updated: October 2026

Corneal dystrophies encompass a heterogeneous group of genetically determined, typically bilateral, symmetric, progressive, non-inflammatory disorders affecting specific cellular layers of the cornea. Historically classified by anatomical layer and biomicroscopic morphology, our modern understanding has been revolutionized by molecular genetics.

1. The IC3D Classification System

The International Committee for Classification of Corneal Dystrophies (IC3D) established an evidence-based hierarchy categorising dystrophies according to the level of genetic and clinical validation (third edition published in 2024):

Category 1 : A well-defined corneal dystrophy in which the gene has been mapped and identified, and specific mutations are known (e.g., TGFBI dystrophies, CHST6 macular dystrophy, SLC4A11 CHED).

Category 2 : A well-defined corneal dystrophy that has been mapped to one or more specific chromosomal loci, but the causative gene has not yet been identified.

Category 3 : A well-defined corneal dystrophy in which the disorder has not yet been mapped to a chromosomal locus.

Category 4 : A suspected or newly identified corneal dystrophy, where clinical, histological, and genetic evidence is not yet convincing that it represents an independent clinical entity.

Summary of IC3D Classification Categories

IC3D Category Genetic Definition Hallmark Examples

Category 1 Gene mapped, cloned, and specific causative mutations sequenced Lattice type 1 ( TGFBI ), Granular type 1 ( TGFBI ), Macular ( CHST6 ), Meesmann ( KRT3 / KRT12 )

Category 2 Locus mapped but causative gene unidentified Evidence category; do not retain ERED here after its gene was identified

Category 3 Distinct clinical phenotype and pedigree; unmapped chromosomal locus Subepithelial mucinous corneal dystrophy (SMCD)

  • Category 4 Suspected dystrophy; doubtful independent entity Polymorphous stromal dystrophy
  • 2. Epithelial & Subepithelial Dystrophies
  • Epithelial Basement Membrane Dystrophy (EBMD / Map-Dot-Fingerprint)

EBMD (also known as Cogan microcystic dystrophy) is the most common anterior corneal dystrophy, affecting up to 2% to 5% of the general population. It is predominantly a sporadic, degenerative, or variable autosomal dominant condition and is not linked to TGFBI .

Histopathology : Basal epithelial cells produce an abnormal, thickened, multilaminar basement membrane that extends into the overlying epithelium. Pockets of degenerating epithelial cells become trapped beneath or within this redundant basement membrane, forming intraepithelial microcysts filled with cellular and cytoplasmic debris.

Biomicroscopic Signs :

Maps : Geographic, circumscribed, grey-white subepithelial patches with scalloped margins.

Dots : Small, discrete, round, white-cream intraepithelial microcysts.

Fingerprints : Concentric, clustered, curved, parallel refractive ridges.

Negative Fluorescein Staining : Elevated ridges cause rapid tear film thinning, producing dark islands against a bright green tear lake.

Clinical Manifestations : Approximately 10% to 30% of affected patients experience recurrent corneal erosions (RCE) manifesting as excruciating pain, tearing, and photophobia upon awakening. Others develop irregular astigmatism and monocular diplopia.

Management : Treat recurrent erosions with lubrication and prevention of lid-related trauma. A monitored bandage contact lens may help selected cases but carries infection risk. Resistant lesions may need epithelial debridement and diamond-burr polishing, peripheral anterior stromal puncture away from the visual axis, or central PTK. Treat associated lid disease; antimicrobial and steroid use requires examination and follow-up.

Meesmann Corneal Dystrophy (Stock-Burch)

An autosomal dominant disorder (Category 1) resulting from missense mutations in keratin 3 ( KRT3 , 12q13) or keratin 12 ( KRT12 , 17q12) , which disrupt the structural integrity of intermediate filaments within basal corneal epithelial cells.

Biomicroscopy : Bilateral, symmetric, countless tiny, clear, round intraepithelial microcysts evenly distributed across the entire cornea, extending fully to the limbus . On retroillumination, microcysts appear like translucent bubbles or glass beads.

Histology & Electron Microscopy : The microcysts contain Periodic acid-Schiff (PAS)-positive, diastase-resistant fibrillogranular material designated the characteristic "peculiar substance" on transmission electron microscopy (TEM).

Course : Asymptomatic in childhood; mild irritation, foreign body sensation, and visual glare emerge in early-to-mid adulthood. PTK is indicated if visual glare is debilitating.

Lisch Epithelial Corneal Dystrophy (LECD)

An autosomal dominant dystrophy associated with MCOLN1 on chromosome 19. Older descriptions of X-linked inheritance have been superseded by IC3D edition 3. Slit-lamp examination demonstrates densely packed, clear microcysts arranged in feather-like, whorled, or flame-shaped bands following the epithelial centripetal migratory lines, sparing the underlying stroma.

3. Bowman Layer Dystrophies

Bowman layer dystrophies (previously considered superficial variants of stromal dystrophies) are autosomal dominant TGFBI -linked conditions resulting in structural degeneration of Bowman layer.

Reis-Bücklers Corneal Dystrophy (CDB1)

Genetics : Autosomal dominant; TGFBI gene on chromosome 5q31, caused primarily by the Arg124Leu mutation.

Clinical Presentation : Severe recurrent erosions starting in early childhood (ages 4 to 5). Visual acuity declines early as irregular astigmatism and superficial stromal haze develop.

Biomicroscopy : Confluent, dense, geographic, grey-white superficial opacities replacing Bowman layer, creating a prominent pebbled, rough epithelial surface.

Histology & Ultrastructure : Bowman layer is fragmented or completely lost, replaced by fibrocellular scar tissue. Stains bright red with Masson trichrome. Electron microscopy confirms rod-shaped or trapezoidal electron-dense bodies identical to those found in granular dystrophy.

Thiel-Behnke Corneal Dystrophy (CDB2 / Honeycomb Dystrophy)

Genetics : Autosomal dominant; primarily caused by the Arg555Gln mutation in TGFBI (locus at 5q31), with an alternative locus identified at 10q23-q24.

Clinical Presentation : Recurrent erosions are milder and arise later in childhood or adolescence compared to Reis-Bücklers. Visual acuity is maintained until middle age.

Biomicroscopy : Symmetrical, subepithelial, reticular opacities arranged in a classic honeycomb or fleck-like pattern , with clear intervening spaces; the peripheral cornea is spared.

Histology & Ultrastructure : Bowman layer exhibits an undulating, "saw-tooth" contour with alternating thick and thin segments. The characteristic ultrastructural feature on transmission electron microscopy is the presence of "curly fibers" (curved, wavy, electro-dense filaments measuring 8 to 10 nm in diameter).

Sections you finish are checked off in the contents.

  • Up Next
  • Stromal corneal dystrophies
  • Continue learning